CN101835492A - 用于制药应用的热动力学混合 - Google Patents
用于制药应用的热动力学混合 Download PDFInfo
- Publication number
- CN101835492A CN101835492A CN200880112353A CN200880112353A CN101835492A CN 101835492 A CN101835492 A CN 101835492A CN 200880112353 A CN200880112353 A CN 200880112353A CN 200880112353 A CN200880112353 A CN 200880112353A CN 101835492 A CN101835492 A CN 101835492A
- Authority
- CN
- China
- Prior art keywords
- thermokinetics
- api
- tkc
- excipient
- described method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Abstract
Description
POLYOX水溶性树脂NF | 25℃,水溶液的粘度范围,mPa·s |
POLYOX水溶性树脂NF WSR N-10 | 30-50(5%溶液) |
POLYOX水溶性树脂NF WSR N-80 | 55-90(5%溶液) |
POLYOX水溶性树脂NF WSR N-750 | 600-1,200(5%溶液) |
POLYOX水溶性树脂NF WSR-205 | 4,500-8,800(5%溶液) |
POLYOX水溶性树脂NF WSR-1105 | 8,800-17,600(5%溶液) |
POLYOX水溶性树脂NF WSR N-12K | 400-800(2%溶液) |
POLYOX水溶性树脂NF WSR N-60K | 2,000-4,000(2%溶液) |
POLYOX水溶性树脂NF WSR-301 | 1,650-5,500(1%溶液) |
POLYOX水溶性树脂NF | 25℃,水溶液的粘度范围,mPa·s |
POLYOX水溶性树脂NF WSR凝结剂 | 5,500-7,500(1%溶液) |
POLYOX水溶性树脂NF WSR-303 | 7,500-10,000(1%溶液) |
材料 | %w/w |
氢化可的松,USP(色谱纯化学品) | 10 |
Kollidon VA 64(BASF Corp.) | 90 |
描述 | 氢化可的松,USP | 经TKC处理的材料 |
杂质-3.2 | 0.20% | 0.20% |
杂质-3.9 | 0.26% | 0.27% |
杂质-4.9 | 0.20% | 0.20% |
杂质-5.5 | 0.62% | 0.64% |
降解产物-7.8 | ND | 0.05% |
杂质-8.7 | 0.13% | 0.10% |
Claims (42)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95704407P | 2007-08-21 | 2007-08-21 | |
US60/957,044 | 2007-08-21 | ||
US5092208P | 2008-05-06 | 2008-05-06 | |
US61/050,922 | 2008-05-06 | ||
PCT/US2008/073913 WO2009026461A2 (en) | 2007-08-21 | 2008-08-21 | Thermo-kinetic mixing for pharmaceutical applications |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101835492A true CN101835492A (zh) | 2010-09-15 |
CN101835492B CN101835492B (zh) | 2012-11-21 |
Family
ID=40378995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008801123533A Active CN101835492B (zh) | 2007-08-21 | 2008-08-21 | 用于制药应用的热动力学混合 |
Country Status (6)
Country | Link |
---|---|
US (6) | US8486423B2 (zh) |
EP (1) | EP2187968A4 (zh) |
JP (4) | JP6073043B2 (zh) |
CN (1) | CN101835492B (zh) |
CA (3) | CA3076115C (zh) |
WO (1) | WO2009026461A2 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102204868A (zh) * | 2011-05-18 | 2011-10-05 | 北京化工大学 | 采用多元辅料制备吲哚美辛速释制剂的热熔挤出工艺 |
CN107205935A (zh) * | 2015-01-20 | 2017-09-26 | 默克专利股份有限公司 | 用聚乙烯醇作载体聚合物的化合物固体分散体 |
CN109069460A (zh) * | 2016-05-09 | 2018-12-21 | 分散技术有限责任公司 | 改进的药物制剂 |
CN109663524A (zh) * | 2017-10-13 | 2019-04-23 | 分散技术有限责任公司 | 用于热动力学熔体共混批次的热敏部分的速度改变的直接进样探头感测温度方法 |
CN111107852A (zh) * | 2017-09-22 | 2020-05-05 | 分散技术有限责任公司 | 阿比特龙-环状寡聚体药物制剂及其形成和施用方法 |
CN111511365A (zh) * | 2017-11-10 | 2020-08-07 | 分散技术有限责任公司 | 改进的药物制剂 |
CN111742041A (zh) * | 2017-12-21 | 2020-10-02 | 丹尼斯科美国公司 | 包含耐热干燥剂的含酶的热熔细粒 |
US11246935B2 (en) | 2016-05-13 | 2022-02-15 | Merck Patent Gmbh | Particle size and distribution of polymer for melt extrusion application |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
US8486423B2 (en) | 2007-08-21 | 2013-07-16 | Board Of Regents, The University Of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
US9545361B1 (en) * | 2011-07-25 | 2017-01-17 | Dispersol Technologies, Llc | Multiple speed process for preserving heat sensitive portions of a thermokinetically melt blended batch |
EP2309990B2 (en) | 2008-06-16 | 2017-03-15 | Pfizer Inc. | Drug loaded polymeric nanoparticles and methods of making and using same |
ES2721850T3 (es) | 2008-06-16 | 2019-08-05 | Pfizer | Nanopartículas poliméricas terapéuticas que comprenden alcaloides vinca y procedimientos de fabricación y uso de las mismas |
US8613951B2 (en) | 2008-06-16 | 2013-12-24 | Bind Therapeutics, Inc. | Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same |
US8809261B2 (en) * | 2008-10-31 | 2014-08-19 | Elsohly Laboratories, Incorporated | Compositions containing delta-9-THC-amino acid esters and process of preparation |
US8563041B2 (en) | 2008-12-12 | 2013-10-22 | Bind Therapeutics, Inc. | Therapeutic particles suitable for parenteral administration and methods of making and using same |
JP2012512175A (ja) * | 2008-12-15 | 2012-05-31 | バインド バイオサイエンシズ インコーポレイテッド | 治療薬を徐放するための長時間循環性ナノ粒子 |
NZ594207A (en) | 2009-02-06 | 2013-03-28 | Egalet Ltd | Immediate release composition resistant to abuse by intake of alcohol |
NZ597283A (en) | 2009-06-24 | 2013-07-26 | Egalet Ltd | Controlled release formulations |
US8357401B2 (en) | 2009-12-11 | 2013-01-22 | Bind Biosciences, Inc. | Stable formulations for lyophilizing therapeutic particles |
ES2780156T3 (es) | 2009-12-15 | 2020-08-24 | Pfizer | Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular |
WO2012116238A1 (en) * | 2011-02-23 | 2012-08-30 | Dispersol Technologies, Llc | PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-β-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS |
US9821283B1 (en) * | 2011-07-25 | 2017-11-21 | Dispersol Technologies, Llc | Direct probe sensed temperature method for speed change for heat sensitive portions of a thermokinetically melt blended batch |
BR112015005940A2 (pt) | 2012-09-17 | 2017-07-04 | Bind Therapeutics Inc | processo para a preparação de nanopartículas terapêuticas |
CN113209024A (zh) * | 2013-12-31 | 2021-08-06 | 阿森迪亚制药有限责任公司 | 疏水性化合物的药物组合物 |
MX2016012009A (es) | 2014-03-14 | 2016-12-05 | Pfizer | Nanoparticulas terapeuticas que comprenden un agente terapeutico, y metodos para su elaboracion y uso. |
CN106232144B (zh) | 2014-03-18 | 2019-12-06 | 武田药品工业株式会社 | 固体分散体 |
HUE057232T2 (hu) * | 2014-04-18 | 2022-04-28 | Dispersol Technologies Llc | Többsebességes eljárás és keverõ termokinetikusan ömlesztve elegyített sarzs hõérzékeny részeinek megõrzésére |
WO2016073421A1 (en) * | 2014-11-03 | 2016-05-12 | Dispersol Technologies, Llc | Improved formulations of vemurafenib and methods of making the same |
CA2989145A1 (en) * | 2015-06-17 | 2016-12-22 | Dispersol Technologies, Llc | Improved formulations of deferasirox and methods of making the same |
TWI799366B (zh) | 2015-09-15 | 2023-04-21 | 美商建南德克公司 | 胱胺酸結骨架平臺 |
JP7376220B2 (ja) * | 2017-09-11 | 2023-11-08 | オースティンピーエックス リミテッド ライアビリティ カンパニー | 熱動力学的に溶融ブレンドされるバッチの熱感受性部分用の、直接プローブにより感知した温度による、速度変更のための方法 |
EP3470133B1 (en) | 2017-10-13 | 2020-09-16 | Dispersol Technologies, LLC | Direct probe sensed temperature method for speed change for heat sensitive portions of a thermokinetically melt blended batch |
EP3492070A1 (en) * | 2017-11-30 | 2019-06-05 | BIT Pharma GmbH | Process and device for preparing a solid dispersion |
US20220401579A1 (en) * | 2019-11-30 | 2022-12-22 | Dispersol Technologies, Llc | Inclusion complexes of pharmaceuticals and cyclic oligomers |
JP2023520018A (ja) | 2020-04-01 | 2023-05-15 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | ニクロサミドの薬学的組成物 |
US20240108639A1 (en) * | 2020-12-11 | 2024-04-04 | Board Of Regents, The University Of Texas System | Compositions and methods of making cocrystals using dielectric heating with dispersive and distributive mixing |
WO2023010030A1 (en) * | 2021-07-27 | 2023-02-02 | Board Of Regents, The University Of Texas System | Improved drug processing methods to increase drug loading |
WO2023034844A1 (en) | 2021-08-31 | 2023-03-09 | Board Of Regents, The University Of Texas System | Delayed release niclosamide formulation |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2319478A1 (fr) * | 1975-07-30 | 1977-02-25 | Gen Electric | Extrudeuse et procede d'extrusion de materiaux thermoplastiques |
US4230615A (en) * | 1978-11-21 | 1980-10-28 | Carlew Chemicals Limited | Process for controlled mixing in a high intensity mixer |
US4628073A (en) * | 1984-10-03 | 1986-12-09 | Monsanto Company | Soft, rubbery, multiphase matrix material and methods for its production |
US4789597A (en) * | 1987-01-12 | 1988-12-06 | Fetherstonhaugh & Co. | Incorporation of chemically reactive agents on resin particles |
EP0580860B2 (en) * | 1991-04-16 | 2004-12-15 | Nippon Shinyaku Company, Limited | Method of manufacturing solid dispersion |
JP2516524B2 (ja) * | 1992-04-27 | 1996-07-24 | 大洋薬品工業株式会社 | 持続性製剤 |
JPH07159587A (ja) | 1993-12-07 | 1995-06-23 | Hitachi Ltd | 樹脂性能モニタ |
JPH07187998A (ja) * | 1993-12-27 | 1995-07-25 | Kao Corp | 錠剤の製造方法 |
GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
US5895790A (en) * | 1995-03-14 | 1999-04-20 | Good; Elmer | Thermosetting wide range polymer blends |
DE19531067A1 (de) | 1995-08-23 | 1997-02-27 | Hermann P T Prof Dr Med Ammon | Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität |
CZ293841B6 (cs) * | 1996-05-20 | 2004-08-18 | Janssenápharmaceuticaán@Áv | Částice s obsahem itrakonazolu |
US6709146B1 (en) * | 2000-07-28 | 2004-03-23 | David Little | Thermokinetic mixer and method of using |
PL367674A1 (en) | 2001-06-22 | 2005-03-07 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
KR20040011248A (ko) | 2002-07-30 | 2004-02-05 | 환인제약 주식회사 | 암로디핀의 고체분산체와 그 제조방법 및 그를 포함하는약학적 조성물 |
CA2509958A1 (en) | 2003-02-03 | 2004-08-19 | Novartis Ag | Pharmaceutical formulation |
GB0319797D0 (en) * | 2003-08-26 | 2003-09-24 | Leuven K U Res & Dev | Particle size reduction of poorly soluble drugs |
US20050158376A1 (en) * | 2003-10-23 | 2005-07-21 | Sardi William F. | Dietary supplement and method of processing same |
WO2005046696A1 (ja) | 2003-11-14 | 2005-05-26 | Ajinomoto Co., Inc. | フェニルアラニン誘導体の固体分散体または固体分散体医薬製剤 |
JP2005263758A (ja) * | 2004-03-22 | 2005-09-29 | Kirin Brewery Co Ltd | 非晶質のn−{2−クロロ−4−[(6,7−ジメトキシ−4−キナゾリニル)オキシ]フェニル}−n’−プロピルウレア |
KR101086254B1 (ko) * | 2004-11-04 | 2011-11-24 | 에스케이케미칼주식회사 | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 |
WO2006105196A2 (en) | 2005-03-28 | 2006-10-05 | Bioresponse, L.L.C. | Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
JP2006347939A (ja) * | 2005-06-15 | 2006-12-28 | Tokyo Printing Ink Mfg Co Ltd | 薬物高分子複合体の製造方法及び薬物高分子複合体 |
JP4429262B2 (ja) * | 2005-12-09 | 2010-03-10 | 壽製薬株式会社 | フェノフィブラートの固体分散体 |
US8486423B2 (en) | 2007-08-21 | 2013-07-16 | Board Of Regents, The University Of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
US9545361B1 (en) * | 2011-07-25 | 2017-01-17 | Dispersol Technologies, Llc | Multiple speed process for preserving heat sensitive portions of a thermokinetically melt blended batch |
JP2012047227A (ja) | 2010-08-25 | 2012-03-08 | Nippon Steel & Sumikin Metal Products Co Ltd | ナット保持部材 |
WO2012116238A1 (en) | 2011-02-23 | 2012-08-30 | Dispersol Technologies, Llc | PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-β-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS |
WO2016073421A1 (en) | 2014-11-03 | 2016-05-12 | Dispersol Technologies, Llc | Improved formulations of vemurafenib and methods of making the same |
-
2008
- 2008-08-21 US US12/196,154 patent/US8486423B2/en active Active
- 2008-08-21 EP EP08798412A patent/EP2187968A4/en not_active Ceased
- 2008-08-21 CN CN2008801123533A patent/CN101835492B/zh active Active
- 2008-08-21 CA CA3076115A patent/CA3076115C/en active Active
- 2008-08-21 JP JP2010522038A patent/JP6073043B2/ja active Active
- 2008-08-21 CA CA2697099A patent/CA2697099C/en active Active
- 2008-08-21 WO PCT/US2008/073913 patent/WO2009026461A2/en active Application Filing
- 2008-08-21 CA CA2990445A patent/CA2990445C/en active Active
-
2013
- 2013-07-15 US US13/942,199 patent/US9339440B2/en active Active
-
2014
- 2014-07-22 JP JP2014148568A patent/JP2014221816A/ja not_active Withdrawn
-
2016
- 2016-04-06 JP JP2016076558A patent/JP2016121195A/ja not_active Withdrawn
- 2016-05-13 US US15/154,083 patent/US10022385B2/en active Active
-
2018
- 2018-06-19 US US16/012,025 patent/US10668085B2/en active Active
- 2018-12-03 JP JP2018226362A patent/JP2019052173A/ja not_active Withdrawn
-
2020
- 2020-05-05 US US16/866,676 patent/US11439650B2/en active Active
-
2022
- 2022-07-25 US US17/814,567 patent/US20230172949A1/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102204868A (zh) * | 2011-05-18 | 2011-10-05 | 北京化工大学 | 采用多元辅料制备吲哚美辛速释制剂的热熔挤出工艺 |
CN107205935A (zh) * | 2015-01-20 | 2017-09-26 | 默克专利股份有限公司 | 用聚乙烯醇作载体聚合物的化合物固体分散体 |
CN109069460A (zh) * | 2016-05-09 | 2018-12-21 | 分散技术有限责任公司 | 改进的药物制剂 |
US11246935B2 (en) | 2016-05-13 | 2022-02-15 | Merck Patent Gmbh | Particle size and distribution of polymer for melt extrusion application |
CN111107852A (zh) * | 2017-09-22 | 2020-05-05 | 分散技术有限责任公司 | 阿比特龙-环状寡聚体药物制剂及其形成和施用方法 |
CN109663524A (zh) * | 2017-10-13 | 2019-04-23 | 分散技术有限责任公司 | 用于热动力学熔体共混批次的热敏部分的速度改变的直接进样探头感测温度方法 |
CN109663524B (zh) * | 2017-10-13 | 2022-07-15 | 分散技术有限责任公司 | 用于热动力学熔体共混批次的热敏部分的速度改变的直接进样探头感测温度方法 |
CN111511365A (zh) * | 2017-11-10 | 2020-08-07 | 分散技术有限责任公司 | 改进的药物制剂 |
CN111742041A (zh) * | 2017-12-21 | 2020-10-02 | 丹尼斯科美国公司 | 包含耐热干燥剂的含酶的热熔细粒 |
Also Published As
Publication number | Publication date |
---|---|
US20200261473A1 (en) | 2020-08-20 |
US9339440B2 (en) | 2016-05-17 |
US20160250230A1 (en) | 2016-09-01 |
EP2187968A2 (en) | 2010-05-26 |
CA3076115C (en) | 2022-06-28 |
CN101835492B (zh) | 2012-11-21 |
US20090053315A1 (en) | 2009-02-26 |
US20180360850A1 (en) | 2018-12-20 |
US11439650B2 (en) | 2022-09-13 |
EP2187968A4 (en) | 2013-02-20 |
CA2697099A1 (en) | 2009-02-26 |
US20230172949A1 (en) | 2023-06-08 |
JP2016121195A (ja) | 2016-07-07 |
US8486423B2 (en) | 2013-07-16 |
JP6073043B2 (ja) | 2017-02-01 |
WO2009026461A2 (en) | 2009-02-26 |
US10668085B2 (en) | 2020-06-02 |
US10022385B2 (en) | 2018-07-17 |
CA2697099C (en) | 2018-02-20 |
WO2009026461A3 (en) | 2009-04-30 |
CA2990445C (en) | 2020-05-05 |
JP2010536877A (ja) | 2010-12-02 |
JP2019052173A (ja) | 2019-04-04 |
CA3076115A1 (en) | 2009-02-26 |
US20130303630A1 (en) | 2013-11-14 |
CA2990445A1 (en) | 2009-02-26 |
JP2014221816A (ja) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101835492B (zh) | 用于制药应用的热动力学混合 | |
CN102056589B (zh) | 包含bibw 2992的固体药物制剂 | |
CN1691965B (zh) | 控释用医药组合物及其制备方法 | |
Keen et al. | Enhancing bioavailability through thermal processing | |
BRPI1010550B1 (pt) | formas de dosagem, e, processo para a produção de preparações para formas de dosagem de substâncias ativas fracamente solúveis em água | |
JP6491669B2 (ja) | Cgrp活性化合物の錠剤製剤 | |
Dhaval et al. | Twin-screw extruder in pharmaceutical industry: history, working principle, applications, and marketed products: an in-depth review | |
JP6189429B2 (ja) | ジエチルアミノエチルメタクリレートコポリマーをベースにした活性成分含有固体分散体 | |
CN105050586B (zh) | 包含非晶西洛他唑的固体分散体 | |
Williams III et al. | Thermo-kinetic mixing for pharmaceutical applications | |
EP4008314A2 (en) | Thermo-kinetic mixing for pharmaceutical applications | |
DiNunzio et al. | Melt extrusion: pharmaceutical applications | |
RU2723255C2 (ru) | Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы | |
US20230114357A1 (en) | Continuous melt-coating of active pharmaceutical ingredients using surfactants for dissolution enhancement | |
DiNunzio et al. | Polymeric interactions with drugs and excipients | |
Bello | Physiochemical and drug release properties of Liquisolid formulations in comparison to their physical mixture counterparts | |
Sandhu et al. | Hot‐Melt Extrusion Technology for Modified‐Release (MR) Formulation Development | |
RU2670447C2 (ru) | Пероральная твердая лекарственная форма с микофенольной кислотой или ее солью для использования в качестве иммунодепрессанта для лечения или предупреждения отторжения трансплантата органа или ткани и способ ее получения | |
WO2024023173A1 (en) | Solid pharmaceutical dosage form comprising a bcs class ii drug and a method for producing the same | |
Keen | Novel formulations and thermal processes for bioavailability enhancement of soluble and poorly soluble drugs | |
Alshetaili | Solubility enhancement, mechanical properties and taste masking of poorly water soluble compounds by optimizing hot melt extrusion processing | |
Singh | Design and development of drug delivery systems for immediate and sustained release utilizing hot melt extrusion | |
Arther Paul | Formulation And Evaluation of Orodispersible Tablets of Domperidone from Selected Solid Dispersions–An Attempt to Improve in Vitro Dissolution, Patient Compliance and Marketability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: DESPAIGNE SPEED TECHNOLOGY LTD. Free format text: FORMER OWNER: INTEGRATED COMPOSITE MATERIAL CORPORATION Effective date: 20150422 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150422 Address after: Texas, USA Patentee after: BOARD OF REGENTS THE University OF TEXAS SYSTEM Patentee after: Despain Speed Technology Co.,Ltd. Address before: Texas, USA Patentee before: BOARD OF REGENTS THE University OF TEXAS SYSTEM Patentee before: INTEGRATED COMPOSITE MATERIAL Corp. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Texas, USA Patentee after: BOARD OF REGENTS THE University OF TEXAS SYSTEM Patentee after: Austin Pharmaceutical Co.,Ltd. Address before: Texas, USA Patentee before: BOARD OF REGENTS THE University OF TEXAS SYSTEM Patentee before: Despain Speed Technology Co.,Ltd. |